Advanced imaging technologies that promise to improve effective drug development to treat lung cancer are the focus of the current issue of Optics Express. Research outlines standardized approaches to measure and compare tumor size, as well as to validate the accuracy of such measurements. This validation is a critical new area of research as important new applications for these tools are being explored in drug development.